Replies to post #5873 on Mind Medicine (MindMed) Inc (MNMD)

[LORTAP KCOTS]

I enjoy having a long term position, and also day trading this for fun in a Roth account(no taxes or capital gains in Roth’s or Ira).
There seems to be a pattern of a short seller in the morning and late afternoon that forces this down and it recovers quickly from that once they let up.

[Sorbytech]

and it looks like theyre planning on the study to be completed by December 2023, so its not that far off to see results for it.
https://clinicaltrials.gov/ct2/show/study/NCT03781128?term=Lysergic+Acid+Diethylamide&draw=2&rank=1
Actual Study Start Date :
January 2, 2019
Estimated Primary Completion Date :
October 2023
Estimated Study Completion Date :
December 2023

[Moonboy1]

This stock is rated a sell by many analysts. They said exactly what I said earlier. And that is this company has no revenue or commercial product of any kind. Nothing but clinical trials with no fda approval on any of them which can take years. GL. I kick myself for not doing more dd before investing. Thought it had finally become a real company with revenue when in fact it was just an uplifting that caused the price to jump and now dump since they have zero revenue and no clear path to commercialization and revenue. Just a lab dosing people and taking notes it looks like. That could be done in the boiler room. GL

[namah sivaya]

Hey mike. Are you sure this phase 2 LSD trial is for addiction or is it for anxiety? Just making sure its not 2 studies concluding...

Seems like anxiety closed as of May 1st.
https://clinicaltrials.gov/ct2/show/NCT03153579?term=Basel+lsd&draw=2